Company HINTO Energy, Inc.

HENI

US4334751009

Investment Holding Companies

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Shell Companies

Market Closed - OTC Markets Other stock markets 01:32:24 2024-05-31 pm EDT			5-day change	1st Jan Change
0.025 ^USD	-3.85%		-3.47%	-71.26%

2022	HINTO Energy, Inc. Went Out of Business	CI
2017	Motion For Case Conversion Approved for HINTO Energy, Inc.	CI

Hinto Energy, Inc., through its rights in JF BioPharma, Inc., is a developer of synthetic late stage schedule1 drugs. The Companyâs focus is on synthetic cannabinoids to treat fibromyalgia, wound care, Type 2 diabetes and cystic fibrosis (CF).

Number of employees: 1

Managers	Title	Age	Since
Joseph Cornwell CEO	Chief Executive Officer	-	23-06-07
Nickolas Korbis COO	Chief Operating Officer	-	23-03-06
Andrew Salzman CTO	Chief Tech/Sci/R&D Officer	68	23-03-06
David Conkling PRN	Corporate Officer/Principal	-	23-03-06

Members of the board	Title	Age	Since
Joseph Cornwell CEO	Chief Executive Officer	-	23-06-07

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	43,040,000	22,770,000 ( 52.90 %)	0	52.90 %

Hinto Energy, Inc.

3 Bethesda Metro Suite 700

20814, Bethesda

Financials

Holding Companies

Holding Companies

Investment Holding Companies

Shell Companies

	1st Jan change	Capi.
HINTO ENERGY, INC.	-71.26%	1.08M
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+180.51%	8.67B
CHURCHILL CAPITAL CORP VII	+2.29%	983M
APPLE ISPORTS GROUP, INC.	+41.91%	883M
PERELLA WEINBERG PARTNERS	+26.17%	825M
ARES ACQUISITION CORPORATION II	+1.92%	665M
E7 GROUP	+9.52%	664M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+9.17%	530M
CAPITOL INVESTMENT CORP. VII	-.--%	500M

Shell Companies